Suscriptores   Asóciese  
Textos Completos Autorizados
MASA OSEA Y MARCADORES DE LA REMODELACION EN MUJERES HIPERTENSAS TRATADAS CON TIAZIDAS

v-estudie-lo-mejor.gif
Expertos Invitados





MASA OSEA Y MARCADORES DE LA REMODELACION EN MUJERES HIPERTENSAS TRATADAS CON TIAZIDAS

(especial para SIIC © Derechos reservados)
Las mujeres hipertensas tratadas con tiazidas presentan un aumento en la densidad mineral ósea y una disminución en los marcadores de remodelación que podría contribuir a explicar el efecto protector que parecen ejercer estos fármacos sobre la osteoporosis.
Autor:
José M. Olmos Martínez
Columnista Experto de SIIC

Institución:
Universidad de Cantabria

Artículos publicados por José M. Olmos Martínez
Coautor
José M. Olmos Martínez* 
Médico, Universidad de Cantabria, Santander, España*
Aprobación
17 de Julio, 2010 		Primera edición
20 de Septiembre, 2010 		Segunda edición, ampliada y corregida
10 de Septiembre, 2021

MASA OSEA Y MARCADORES DE LA REMODELACION EN MUJERES HIPERTENSAS TRATADAS CON TIAZIDAS


Artículo completo
(castellano)
Extensión:  +/-3.29 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes
Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Medicina Interna, Osteoporosis y Osteopatías Médicas
Relacionadas: Atención Primaria, Cardiología, Diagnóstico por Laboratorio, Endocrinología y Metabolismo, Ortopedia y Traumatología, Reumatología



Comprar este artículo
Extensión: 3.29 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
José M Olmos, Department of Internal Medicine Hospital Universitario Marqués de Valdecilla Universidad de Cantabria, Santander, España
Bibliografía del artículo
Alenfeld FM, Engelke K, Schmidt T, Bredzger M, Diessel E, Felsenberg D. Diagnostic agreement of two calcaneal ultrasound devices: the Sahara bone sonometer and the Achilles+. Br J Radiol 75:895-902, 2002.
Barry EL, Gesek FA, Kaplan MR, Herbert SC, Friedman PA. Expression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics. Am J Physiol 272:C109-C116, 1997.
Bauer DC, Browner WS, Cauley JA, Orwoll ES, Scott JC, Black DM, et al. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 118:657-665, 1993.
Berry EM., Gupta MM, Turner SJ, Burns RR. Variations in plasma calcium with induced changes in plasma specific gravity, total protein, and albumin. Br Med J IV:640-643, 1973.
Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 18:479-486, 2007.
Cappuccio FP, Meihlan E, Zmuda JM, Cauley JA. High blood pressure and bone mineral loss in elderly white women: a prospective study. Lancet 354:971-975, 1999.
Cauley JA, Cummings SR, Seeley DG, Black D, Browner W, Kuller LH, et al. Effects of thiazide diuretic therapy on bone mass, fractures, and falls. The study of Osteoporotic Fractures Research Group. Ann Intern Med 118:666-673, 1993.
Díez A, González-Macías J, Marín F, Abizanda M, Alvarez R, Gimeno A, et al., for the ECOSAP study investigators. Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int 18:629-639, 2007.
Feskanisch D, Willet WC, Stampfer JM, Golditz GA. A prospective study of thiazide use and fractures in women. Osteoporos Int 7:79-84, 1997.
Garnero P, Borel O, Delmas PD. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 47:694-702, 2001.
Garnero P, Vergnaud P, Hoyle N. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem 54:188-196, 2008.
Hanley DA, Brown JP, Tenenhause A, Olszynski WP, Toannidis G, Berger C, et al. Associations between disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results of the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 18:784-790, 2003.
Kamel HK. Low-dose thiazide and bone density. Lancet 136:252-253, 2002.
La Croix AZ, Wienpahl J, White LR, et al. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 322:286-290, 1990.
LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE. Low-dose hydroclorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 133:516-526, 2000.
Lajeunesse D, Menard P, Morceau R, Hamel L. Direct effects of thiazides on the human osteosarcoma cell line MG-63. J Bone Miner Res 9:S355, 1994.
Lalande A, Roux S, Denne MA, Stanley ER, Schiavi P, Guez D, et al. Indapamide, a thiazide diuretic decrease bone resorption in vitro. J Bone Miner Res 16:361-370, 2001.
Lemann JJ, Gray RW, Malerhofer WJ, Cheung HS. Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations. Kidney Int 28:951-958, 1985.
Melton LJ III, Chrischilles EA, Cooper C, Lane AW, Riggs BL. How many women have osteoporosis? J Bone Miner Res 7:1005-1010, 1992.
Middler S, Pack CY, Murad F, Bartter FC. Thiazide diuretics and calcium metabolism. Metabolism 22:139-146, 1973.
Mussolino ME, Gillum RF. Bone mineral density and hypertension prevalence in postmenopausal women: results from the Third National Health and Nutrition Examination Survey. Ann Epidemiol 16:395-399, 2006.
Nowack R, Hofner MC, Reichel H, Schmidt Gayk H, Ritz E. Subacute effects of thiazide administration on renal hemodynamics and calcium metabolism. Clin Invest 70:689-691, 1992.
Ott SM, La Croix AZ, Scholles D, Ichikawa LE, Wu K. Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly prsons. Osteoporos Int 19:1315-1322, 2008.
Peh CA, Horowitz M, Wishart JM, Need AG, Morris HA, Nordin BE. The effect of chlorothiazide on bone-related biochemical variables in normal postmenopausal women. J Am Geriatr Soc 41:513-516, 1993.
Pérez Castrillón JL, Justo I, Silva J, Sanz A, Igea R, Escudero P, et al. Bone mass and bone modelling markers in hypertensive postmenopausal women. J Hum Hypertens 17:107-110, 2003.
Pérez-Castrillón JL, Justo I, Sanz-Cantalapiedra A, Pueyo C, Hernández G, Dueñas A. Effect of the antihypertensive treatment on the bone mineral density and osteoporotic fracture. Current Hypertension Rev 1:61-66, 2005.
Pierce WM, Nardin GF, Fuqua MF, Sabah-Maren E, Stern SH. Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women. J Bone Miner Res 6:347-354, 1991.
Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM, Evans MC, et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 109:362-370, 2000.
Rejnmark L, Vestergaard P, Heickendorff L, Adreansen F, Mosekilde L. Effects of thiazide- and loop-diuretics, alone or in combination, on calciotropic hormmones and biochemical bone markers: a randomized controlled study. J Intern Med 250:144-153, 2001.
Renjmark L, Vestergaard P, Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76:167-175, 2005.
Reusz GS, Dobos M, Vasarhely B, Sallay P, Szabo A, Horvath C, et al. Sodium transport and bone mineral density in hypercalciuria with thiazide treatment. Pediatr Nephrol 12:30-34, 1998.
Riancho JA, Valero C, Hernández JL, Olmos JM, Paule B, Zarrabeitia A, González-Macías J. Biomechanical indices of the femoral neck estimated from the Standard DXA output: Age- and sex-related differences. J Clin Densitomet 10:39-45, 2007.
Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med 139:476-482, 2000.
Sigurdson G, Franzson L. Incrased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels. J Intern Med 250:51-56, 2001.
Sosa M, Saavedra P, Muñoz M, Alegre J, Gómez C, González Macías J, et al., and the GIUMO Study Group. Quantitative ultrasound calcaneus measurements: normative data and precision in the Spanish population. Osteoporos Int 13:487-492, 2002.
Steiniche T, Mosekilde L, Christensen MS, Melsen F. Histomorphometric analysis of bone in idiopatic hypercalciuria before and after treatment with thiazides. APMIS 97:302-308, 1989.
Sun J, Elwood W, Barnes PJ, Chung KF. Effect of thiazide diuretics against neurally mediated contraction of guinea pig airways: contribution of carbonic anhydrase. Am Rev Respir Dis 148:902-908, 1993.
Transbol I, Christensen M,S, Jensen GF, Christiansen C, McNair P. Thiazide for the postponement of postmenopausal bone loss. Metabolism 31:383-386, 1982.
Tsuda K, Nistui I, Masuyama Y. Bone mineral density in women with essential hypertension. Am J Hypertens 14:704-707, 2001.
van Daele PL, Burguer H, Algra D, Hofman A, Grobbee DE, Birkenhager JC, Pols HA. Age-associated changes in ultrasound measurements of the calcaneus in men and women: the Rotterdam study. J Bone Miner Res 9:1751-1757, 1994.
Wasnick RD, Davis J, Ross P, Vogel J. Effect of thiazide on rates of bone mineral loss: a longitudinal study. Br Med J 301:1303-1305, 1990.
Wasnick RD, Davis JW, He YF, Petrovic H, Ross PD. A randomized, double-masked, placebo-controlled trial of chlortalidone and bone loss in elderly women. Osteoporos Int 5:247-251, 1995.
WHO study group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843. Geneva: WHO, 1994.
Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T. Serum pentosidine levels are positively associated with the presence of vertebral fractures on postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 93:1013-1019, 2008.
Título español
 Bibliografía
 Artículo completo
(exclusivo a suscriptores)
 Autoevaluación
  Tema principal en SIIC Data Bases
 Especialidades

  English title
  Abstract
 Key words
Full text
(exclusivo a suscriptores)

Autor 
Artículos
Correspondencia
Patrocinio y reconocimiento
Imprimir esta página
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Acerca de SIIC   Estructura de SIIC   Fuentes informativas  

Sociedad Iberoamericana de Información Científica

Copyright siicsalud© 1997-2024 ISSN siicsalud: 1667-9008
ua31517